These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Abnormal chromatin clumping in leucocytes: a clue to a new subtype of myelodysplastic syndrome. Jaén A; Irriguible D; Milla F; Vallespi T; Torrabadella M; Abella E; Lafuente R; Woessner S Eur J Haematol; 1990 Oct; 45(4):209-14. PubMed ID: 2226739 [TBL] [Abstract][Full Text] [Related]
11. Clonal haemopoiesis in normal elderly women: implications for the myeloproliferative disorders and myelodysplastic syndromes. Champion KM; Gilbert JG; Asimakopoulos FA; Hinshelwood S; Green AR Br J Haematol; 1997 Jun; 97(4):920-6. PubMed ID: 9217198 [TBL] [Abstract][Full Text] [Related]
12. Studies on blood and bone marrow findings of myelodysplastic syndromes: evaluation of proposals for classification of myelodysplastic syndromes. Yang CL; Li LQ; Chen WJ; Yang TY; Sun YM; Li XY Proc Chin Acad Med Sci Peking Union Med Coll; 1988; 3(1):7-11. PubMed ID: 3174618 [No Abstract] [Full Text] [Related]
13. Red cell hypoplasia, thrombocytosis, and leucocytosis: myelodysplastic and proliferative syndrome. Craig A; Geary CG; Love EM; Liu-Yin J J Clin Pathol; 1988 Nov; 41(11):1168-70. PubMed ID: 3145289 [TBL] [Abstract][Full Text] [Related]
15. Association between myeloid malignancies and acquired deficit in protein 4.1R: a retrospective analysis of six patients. Alanio-Bréchot C; Schischmanoff PO; Fénéant-Thibault M; Cynober T; Tchernia G; Delaunay J; Garçon L Am J Hematol; 2008 Apr; 83(4):275-8. PubMed ID: 17994571 [TBL] [Abstract][Full Text] [Related]
16. Acute myeloblastic leukemia with trilineage myelodysplasia and CD34+ blast cells with abnormal chromatin clumping. Gil S; Luño E; Rodriguez JA Haematologica; 1998 Aug; 83(8):750-1. PubMed ID: 9793262 [TBL] [Abstract][Full Text] [Related]
17. Expression of the c-kit proto-oncogene in myeloproliferative disorders and myelodysplastic syndromes. Siitonen T; Savolainen ER; Koistinen P Leukemia; 1994 Apr; 8(4):631-7. PubMed ID: 7512174 [TBL] [Abstract][Full Text] [Related]
18. Soluble FAS (CD95) is not elevated in the serum of patients with myeloid leukemias, myeloproliferative and myelodysplastic syndromes. Munker R; Midis G; Owen-Schaub L; Andreff M Leukemia; 1996 Sep; 10(9):1531-3. PubMed ID: 8751476 [TBL] [Abstract][Full Text] [Related]
19. G-CSF priming, clofarabine, and high dose cytarabine (GCLAC) for upfront treatment of acute myeloid leukemia, advanced myelodysplastic syndrome or advanced myeloproliferative neoplasm. Becker PS; Medeiros BC; Stein AS; Othus M; Appelbaum FR; Forman SJ; Scott BL; Hendrie PC; Gardner KM; Pagel JM; Walter RB; Parks C; Wood BL; Abkowitz JL; Estey EH Am J Hematol; 2015 Apr; 90(4):295-300. PubMed ID: 25545153 [TBL] [Abstract][Full Text] [Related]
20. Vitamin D insufficiency in myeloproliferative neoplasms and myelodysplastic syndromes: clinical correlates and prognostic studies. Pardanani A; Drake MT; Finke C; Lasho TL; Rozell SA; Jimma T; Tefferi A Am J Hematol; 2011 Dec; 86(12):1013-6. PubMed ID: 22086864 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]